We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Screw-Shaped Magnetic Microrobots to Transform Treatment for Patients with Inoperable Blood Clots

By HospiMedica International staff writers
Posted on 26 Feb 2025

Cardiovascular conditions such as thrombosis pose a significant global health issue, with blood clots being responsible for one in four deaths worldwide each year. More...

A blood clot can obstruct a blood vessel, preventing oxygenated blood from reaching certain parts of the body. Traditional treatments often struggle to address clots located in hard-to-reach areas. Now, the development of magnetic microrobots offers new hope for patients dealing with otherwise inoperable blood clots.

Researchers at the University of Twente (Enschede, Netherlandsl) and Radboud University Medical Center (Nijmegen, Netherlands) have successfully developed wireless magnetic robots to remove blood clots. This cutting-edge innovation is poised to revolutionize the treatment of life-threatening vascular conditions such as thrombosis. The robots are 3D-printed in the shape of tiny screws, each containing a small permanent magnet. The magnet, measuring only one millimeter in length and diameter, is strategically positioned to allow the "screw" to rotate in both directions. This capability enables the robot to move against the blood flow and then reverse direction to swim back, making it highly maneuverable. The screw design enhances its ability to effectively drill through blood clots. These microrobots are controlled wirelessly, enabling them to navigate through the complex network of blood vessels.

The study explored three approaches for removing blood clots: mechanical fragmentation, chemical dissolution, and a combination of both. The combined approach proved to be the most reliable and safe, as it both fragments the clots and dissolves the resulting pieces. Using X-ray guidance, the tiny robots can precisely target clots within intricate blood vessels. In a recent study published in Applied Physics Reviews, the researchers demonstrated the potential of these microrobots for precise, minimally invasive clot removal. During their experiments, the robots were able to remove enough of a blood clot in the iliac artery, sourced from sheep, to restore blood flow. The iliac artery was chosen due to its straight and accessible structure, which made it an ideal model for testing. Beyond just breaking up blood clots and restoring blood flow, the technology also shows promise for other applications, such as targeted drug delivery. The robots can deliver medication directly to specific areas in the body, reducing the risk of side effects in unaffected regions.

“These robots are designed to swim and perform surgeries deep inside the body, but researchers have been limited to using clear models and video cameras, or ultrasonic probes with limited range," said Aaron Becker, researcher at the University of Houston. “Real-time X-ray guidance of these tiny robots is an essential leap forward in this area. We’ve long imagined what it looks like, but now we have 3D reconstructions of blood clots as the robot dissolves them.”

Related Links:
University of Twente
Radboud University Medical Center 


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Lateral Lumbar Interbody Spacer
CALIBER-L
New
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.